Alkem develops anti-diabetic, anti-malarial, cardiovascular, immunosuppressants, nutraceuticals and pain management products.
Alkem Labs's headquarters is in Mumbai, Maharashtra. Alkem Labs has a revenue of $138.3M, and 129 employees. Alkem Labs's investors include Abu Dhabi Investment Fund, Morgan Stanley, and Apax Global. Alkem Labs's main competitors are Cipla, Biocon and Dr Reddys Laboratories.
Not enough data available
Please download Hush app to participate in Surveys!